Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
复制标题
DOI:
10.1158/0008-5472.can-09-1043
复制
发表时间:
2009-12-01
期刊:
影响因子:
11.2
通讯作者:
Sloane BF
中科院分区:
文献类型:
--
作者:
Jedeszko C;Victor BC;Podgorski I;Sloane BF
Stromal-derived hepatocyte growth factor (HGF) acting through its specific proto-oncogene receptor c-Met has been suggested to play a paracrine role in the regulation of tumor cell migration and invasion. The transition from pre-invasive ductal carcinoma in situ (DCIS) to invasive breast carcinoma is marked by infiltration of stromal fibroblasts and the loss of basement membrane. We hypothesized that HGF produced by the infiltrating fibroblasts may alter proteolytic pathways in DCIS cells and to study this hypothesis established 3D reconstituted basement membrane overlay co-cultures with two human DCIS cell lines: MCF10.DCIS and SUM102. Both cell lines formed large dysplastic structures in 3D cultures that resembled DCIS in vivo and occasionally developed invasive outgrowths. In co-culture with HGF-secreting mammary fibroblasts, the percentage of DCIS structures with invasive outgrowths was increased. Activation of c-Met with conditioned media from HGF-secreting fibroblasts or with recombinant HGF increased the percentage of DCIS structures with invasive outgrowths, their degradation of collagen IV and their secretion of urokinase plasminogen activator and its receptor. In agreement with the in vitro findings, co-injection with HGF-secreting fibroblasts increased invasiveness of MCF10.DCIS xenografts in SCID mice. Our study demonstrates that paracrine HGF/c-Met signaling between fibroblasts and pre-invasive DCIS cells enhances the transition to invasive carcinomas and suggests that 3D co-cultures are appropriate models for testing therapeutics that target tumor microenvironment-enhanced invasiveness.